In conclusion, we believe that this is the first study to evaluate the prognostic and predictive value of ERCC1 gene alteration, ERCC1 mRNA expression, and GSTP1 polymorphism in patients with unresectable or recurrent gastric cancer. Here, ERCC1 is linked to gastric cancer.